Oral colonization and immune responses to Streptococcus gordonii: Potential use as a vector to induce antibodies against respiratory pathogens

Current Opinion in Infectious Diseases

Volumn 16, Issue 3, 2003, Pages 231-235

  Lee, Song F ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Mucosal immune response; Respiratory pathogens; Streptococcus gordonii

Indexed keywords

ANTIBODY; BACTERIAL ANTIGEN; CYTOKINE; DIPHTHERIA TOXIN; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PERTUSSIS TOXIN; VIRUS ANTIGEN;

ANTIGEN EXPRESSION; BACTERIAL COLONIZATION; BACTERIAL IMMUNITY; BORDETELLA PERTUSSIS; CELL SURFACE; CORYNEBACTERIUM DIPHTHERIAE; DRUG DELIVERY SYSTEM; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOMODULATION; MOUTH CAVITY; NONHUMAN; PORPHYROMONAS GINGIVALIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; REVIEW; STREPTOCOCCUS GORDONII; STREPTOCOCCUS PYOGENES; VIRUS;

EID: 0037945199     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200306000-00008     Document Type: Review

References (32)

1. Brey RN, Bixler GS, Fulginiti JP, et al. Oral delivery of antigens in live bacterial vectors. Adv Exp Med Biol 1991; 303:169-184.
2. Hoiseth SK, Stocker BA. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981; 291:238-239.
3. Ryan ET, Crean TI, Kochi SK, et al. Development of a DeltaglnA balanced lethal plasmid system for expression of heterologous antigens by attenuated vaccine vector strains of Vibrio cholerae. Infect Immun 2000; 68:221-226.
4. Medaglini D, Pozzi G, King TP, Fischetti V. Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization. Proc Natl Acad Sci U S A 1995; 92:6868-6872.
5. Lee SF, March RJ, Halperin SA, et al. Surface expression of a protective recombinant pertussis toxin S1 subunit fragment in Streptococcus gordonii. Infect Immun 1999; 67:1511-1516.
6. Grangette C, Muller-Alouf H, Goudercourt D, et al. Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum. Infect Immun 2001; 69:1547-1553.
7. Hansson M, Stalh S, Nguyen T, et al. Expression of recombinant proteins on the surface of the coagulase-negative bacterium Staphylococcus xylosus. J Bacteriol 1992; 174:4239-4245.
8. Oggioni MR, Medaglini D, Maggi T, Pozzi G, Engineering the gram positive cell surface for construction of bacterial vaccine vectors. Methods 1999; 19:163-173.
9. Carlsson J, Grahnen H, Jonsson G, et al. Early establishment of Streptococcus salivarius in the mouth of infants. J Dent Res 1970; 49:415-418.
10. Smith DJ, Taubman MA. Ontogeny of immunity to oral microbiota in humans. Crit Rev Oral Biol Med 1992; 3:109-133.
11. Arnold RR, Mestecky J, McGhee JR. Naturally occurring secretory immunoglobulin A antibodies to Streptococcus mutans in human colostrum and saliva. Infect Immun 1976; 14:355-362.
12. Lehtonen OPJ, Grahn EM, Stahlberg TH, Laitinen LA. Amount and avidity of salivary and serum antibodies against Streptococcus mutans in two groups of human subjects with different dental caries susceptibility. Infect Immun 1984; 43:308-313.
13. Allansmith MR, Burns CA, Arnold RR. Comparison of agglutinin titers for Streptococcus mutans in tears, saliva, and serum. Infect Immun 1982; 35;202-205.
14. Luo Z, Smith DJ, Taubman MA, King WF, Cross-sectional analysis of serum antibody to oral streptococcal antigens in children. J Dent Res 1988; 67:554-560.
15. Sharma A, Honma K, Evans RT, et al. Oral immunization with recombinant Streptococcus gordonii expressing Porphyromonas gingivalis FimA domains. Infect Immun 2001; 69:2928-2934. This provides the best evidence to date showing the potential of oral immunization with S. gordonii.
16. Mazmanian SK, Schneewind O. Cell wall-anchored surface proteins and lipoproteins of Gram-positive bacteria. In: Sonenshein AL, Hoch JA, and Losick R, editors. Bacillus subtilis and its closet relatives: from genes to cells. Washinton, DC: American Society for Microbiology; 2001. pp. 150-180.
17. Bolken TC, Franke CA, Jones KF, et al. Inactivation of the srtA gene in Streptococcus gordonii inhibits cell wall anchoring of surface proteins and decreases in vitro and in vivo adhesion. Infect Immun 2001; 69:75-80. The paper provides some insights to the mechanism of protein surface localization in S. gordonii.
18. Lee SF, Boran T. Roles of sortase in surface expression of the major protein adhesin SpaP, saliva-induced aggregation and adherence, and cariogenicity of Streptococcus mutans. Infect Immun 2003; 71:676-681. This paper shows P1 antigen is surface-localized in S. mutans by sortase. Taken together with Ref. [17•], the common mechanism of protein surface expression is evidenced.
19. Lee CW, Lee SF, Halperin SA. Surface expression of a recombinant mutant fragment A of diphtheria toxin in Streptococcus gordonii [abstract]. The 102nd Annual Meeting of the American Society for Microbiology; May 19-23; Salt Lake City. Washington DC: American Society for Microbiology; 2002, p. 185.
20. Byrd CM, Bolken TC, Jones KF, et al. Biological consequences of antigen and cytokine co-expression by recombinant Streptococcus gordonii vaccine vectors. Vaccine 2002; 20:2197-2295. This paper outlines a novel approach to modulate immune responses by co-expressing cytokines and a heterologous antigen by S. gordonii. This may be a way to increase immune response to S. gordonii.
21. Maggi T, Spinosa M, Ricci S, et al. , Genetic engineering of Streptococcus gordonii for the simultaneous display of two heterologous proteins at the bacterial surface. FEMS Microbiol Letts 2002; 210:135-141. Two antigens from two different pathogens may be expressed on the surface of S. gordonii at the same time.
22. Pozzi G, Controni M, Oggioni MR, et al. Delivery and expression of a heterologous antigen on the surface of streptococci. Infect Immun 1992; 60:1902-1907.
23. Ricci S, Medaglini D, Rush CM, et al. Immunogenicity of the B monomer of Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii. Infect Immun 2000; 68:760-766.
24. Medaglini D, Ciabattini A, Spinosa MR, et al. Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice. Vaccine 2001; 19:1931-1939. This paper shows that parenteral and oral immunization provided protection to the animals. The finding suggests the potential of oral colonization in prevention of infectious diseases.
25. Sharma A, Sojar HT, Hruby DE, et al. Secretion of Porphyromonas gingivalis fimbrillin polypeptides by recombinant Streptococcus gordonii. Biochem Biophys Res Comm 1997; 238:313-316.
26. Lee SF, Halperin SA, Knight JB, Tait A. Purification and immunogenicity of a recombinant Bordetella pertussis SIS3FHA fusion protein expressed by Streptococcus gordonii. Appl Environ Microbiol 2002; 68:4253-4258. The findings indicate that multiple antigens from a respiratory pathogen can be expressed as a single fusion protein by S. gordonii.
27. Sivam S, Lee CW, Lee CW, Halperin SA. Expression of a trivalent pertussis, diphtheria and tetanus toxin fusion protein in Escherichia coli and Streptococcus mutans [abstract]. The 70th Conjoint Meeting on Infectious Diseases; November 3-6; Halifax. Toronto: Canadian Association for Clinical Microbiology and Infectious Diseases; 2002. p. 76.
28. Sharma A, Nagata H, Hamada N, et al. Expression of functional Porphyromonas gingivalis fimbrillin polypeptide domains on the surface of Streptococcus gordonii. Infect Immun 1996; 62:3933-3938.
29. Lee SF, Halperin SA, Wang H, MacArthur A. Oral colonization and immune responses to Streptococcus gordonii expressing a pertussis toxin S1 fragment in mice. FEMS Microbiol Letts 2002; 208:175-178. This describes a long-term and great extent of colonization by recombinant S. gordonii that led to a mucosal immune response.
30. Corinti S, Medaglini D, Cavani A, et al. Human dendritic cells very efficiently present a heretologous antigen expressed on the surface of recombinant gram-positive bacteria to CD4+ T lymphocytes. J Immunol 1999; 163:3029-3036.
31. Rescigno M, Citterio S, Thery C, et al. Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells. Proc Natl Acad Sci U S A 1998; 95:5229-5234.
32. Corinti S, Medaglini D, Prezzi C, et al. Human dendritic cells are superior to B cells at presenting a major histocompatibility complex class II-restricted heterologous antigen expressed on recombinant Streptococcus gordonii. Infect Immun 2000; 68:1879-1883.